Latest Breaking News On - Nadav friedmann - Page 1 : comparemela.com
Cassava Sciences (SAVA) Announces Passing of Board Member Nadav Friedmann
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer s Disease
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer s Disease
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Cassava Sciences’ Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim .
Cassava Sciences, Inc.February 2, 2021 GMT
- Patients’ Cognition Improved 1.6 Points on ADAS-Cog11 -
- Patients’ Behavior Improved 1.3 Points on NPI -
- Improvements Maintained at 6 Months -
- Results Support Advancing Simufilam into Phase 3 Clinical Program -
AUSTIN, Texas, Feb. 02, 2021 (GLOBE NEWSWIRE) Cassava Sciences, Inc. (Nasdaq: SAVA) today announced results of an interim analysis from an open-label study of simufilam, its lead drug candidate for the treatment of Alzheimer’s disease. Patients’ cognition and behavior scores both improved following six months of simufilam treatment, with no safety issues.